Bodolay Edit, Seres Ildiko, Szodoray Peter, Csípo Istvan, Jakab Zsanett, Vegh Judit, Szilagyi Anna, Szegedi Gyula, Paragh Gyorgy
Division of Clinical Immunology, 3rd Department of Internal Medicine, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary.
J Rheumatol. 2008 Feb;35(2):237-43. Epub 2007 Dec 15.
Mixed connective tissue disease (MCTD) is a systemic inflammatory autoimmune disease. The connection between inflammatory measures and atherosclerosis in MCTD has not been described. Paraoxonase (PON) is known to have an antioxidant function. We evaluated lipid profiles and PON activity in patients with MCTD.
Thirty-seven patients with MCTD were enrolled. Patients had taken no antihyperlipidemic drugs in the past 2 months. Thirty healthy individuals served as controls. The mean age of patients was 51.2 +/- 9.5 years; disease duration was 11.0 +/- 7.2 years. PON activity was determined with spectrophotometry, von Willebrand factor (vWF) antigen was investigated with the immunoturbidimetry method, and thrombomodulin and antiendothelial cell antibody (AECA) measurements were carried out by ELISA.
PON activity in patients with MCTD was significantly lower than in the controls (patients 118.5 +/- 64.6 U/l, controls 188.0 +/- 77.6; p < 0.001). Arylesterase activity was significantly reduced in patients (p < 0.001). Reduction of PON activity showed a close correlation with the age of the patients, duration of the disease, and vascular events (eye, cardiac, cerebral). There was a close association between the low PON activity and endothelial cell activation markers (thrombomodulin, vWF, AECA).
Our results indicate that in patients with MCTD there is an increased risk for atherosclerosis. In the development of atherosclerosis, besides the elevated levels of cholesterol and triglyceride, reduced PON concentrations and PON activity may play a crucial role.
混合性结缔组织病(MCTD)是一种全身性炎症性自身免疫性疾病。尚未描述MCTD中炎症指标与动脉粥样硬化之间的联系。对氧磷酶(PON)已知具有抗氧化功能。我们评估了MCTD患者的血脂谱和PON活性。
纳入37例MCTD患者。患者在过去2个月内未服用过抗高脂血症药物。30名健康个体作为对照。患者的平均年龄为51.2±9.5岁;病程为11.0±7.2年。用分光光度法测定PON活性,用免疫比浊法检测血管性血友病因子(vWF)抗原,用酶联免疫吸附测定法(ELISA)检测血栓调节蛋白和抗内皮细胞抗体(AECA)。
MCTD患者的PON活性显著低于对照组(患者118.5±64.6 U/l,对照组188.0±77.6;p<0.001)。患者的芳基酯酶活性显著降低(p<0.001)。PON活性降低与患者年龄、病程和血管事件(眼部、心脏、脑部)密切相关。低PON活性与内皮细胞活化标志物(血栓调节蛋白、vWF、AECA)之间存在密切关联。
我们的结果表明,MCTD患者发生动脉粥样硬化的风险增加。在动脉粥样硬化的发展过程中,除了胆固醇和甘油三酯水平升高外,PON浓度降低和PON活性降低可能起关键作用。